Acer Therapeutics gains after re-acquiring drug rights
30/08/2023 23:26
** Acer Therapeutics ACER.O up ~5% at 64 cents in extended
trading
** Co re-acquires worldwide development, commercialization,
and economic rights to Olpruva from Relief Therapeutics,
excluding geographical Europe
** ACER lost 75% value, YTD
(Reporting by Pratyush Thakur)
((Pratyush.Thakur@thomsonreuters.com))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31